Table 3.
Factors Associated With Risk for HCC*
| Features | HR (95% CI) | P Value | |
|---|---|---|---|
| Fibrosis | F0-F1 | 1 | |
| F2 | 0.883 (0.411-1.897) | 0.749 | |
| F3 | 1.347 (0.624-2.906) | 0.448 | |
| F4 | 3.133 (1.536-6.390) | 0.002 | |
| AFP | <6 ng/mL | 1 | |
| 6-20 ng/mL | 1.710 (0.963-3.038) | 0.067 | |
| ≥20 ng/mL | 3.417 (1.807-6.460) | <0.001 | |
| Age | <57 years | 1 | |
| ≥57 years | 2.039 (1.278-3.252) | 0.003 | |
| IFN therapy | No therapy | 1 | |
| Non-SVR | 0.729 (0.467-1.137) | 0.163 | |
| SVR | 0.089 (0.027-0.288) | <0.001 | |
| WFA+-M2BP | <1 | 1 | |
| 1-4 | 5.155 (1.180 − 22.500) | 0.029 | |
| ≥4 | 8.318 (1.784 − 38.791) | 0.007 | |
Abbreviations: HR, hazard ratio; CI, confidence interval.
*
Determined by multivariate analysis.